A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment
Clinical trial NCT01429623 · COMPLETED
Trial details
- NCT number
- NCT01429623
- Sponsor
- Avraham Pharmaceuticals Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2016-07-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.